Effectiveness of ARNI (Angiotensin II Receptor Blocker Neprilysin Inhibitor) therapy in advanced HFrEF in reduction of severe functional mitral regurgitation
27 May 2018 (08:30 - 18:00)
Organised by:
Abstract
About the speaker
Medical University of Lodz, Lodz (Poland)
3 More presentations in this session
Access the full session
The Event
Heart Failure 2018
27 May 2018
08:30 CET
You may be interested in
Congress Presentation
25 August 2023
Webinar
12 December 2018
Congress Presentation
